Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

anti-CD19 CAR-T cell therapy

Home Drugsanti-CD19 CAR-T cell therapy

anti-CD19 CAR-T cell therapy

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Methods of treating lupus nephritis using anti-CD19 CAR-T cell therapy
Applicant: KEVENER MEDICAL INCPriority: 2022
CN
Methods of treating stiff human syndrome and myasthenia gravis using anti-CD19 CAR-T cell therapy
Applicant: KEVENER MEDICAL INCPriority: 2023
CN
KPNA2 overexpressed CD19 CAR-T cell as well as preparation method and application thereof
Applicant: LIANGZHU LABORATORYPriority: 2025
CN
Humanized antigen-binding domains and methods of use
Applicant: KITE PHARMA INCPriority: 2018
US
2 publications
DESIGN AND COMPOSITION OF HUANTI-CD19 CHIMERIC ANTIGEN RECEPTOR TARGETING B-CELL MALIGNANCIES THEREOF
Applicant: LYSINE BIOTECH PRIVATE LTDPriority: 2023
US
Construction and application of anti-human CD19 chimeric antigen receptor gene for knocking down interferon gamma
Applicant: HANGZHOU YONGSHEN BIOLOGICAL TECH CO LTDPriority: 2023
CN
COMBINATION THERAPY OF A CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY AND A KINASE INHIBITOR
Applicant: JUNO THERAPEUTICS INCPriority: 2018
CN
Chimeric antigen receptor targeting CD19 and application thereof
Applicant: UNIV SHANGHAI TECHNOLOGYPriority: 2022
CN